1. Home
  2. BELFA vs FTRE Comparison

BELFA vs FTRE Comparison

Compare BELFA & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bel Fuse Inc.

BELFA

Bel Fuse Inc.

HOLD

Current Price

$182.25

Market Cap

1.6B

Sector

N/A

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$17.36

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BELFA
FTRE
Founded
1949
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BELFA
FTRE
Price
$182.25
$17.36
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$15.50
AVG Volume (30 Days)
54.9K
1.2M
Earning Date
02-17-2026
03-02-2026
Dividend Yield
0.13%
N/A
EPS Growth
19.52
N/A
EPS
5.17
N/A
Revenue
$649,376,000.00
$2,759,900,000.00
Revenue This Year
$28.52
$3.17
Revenue Next Year
$6.49
$0.07
P/E Ratio
$35.93
N/A
Revenue Growth
23.70
1.88
52 Week Low
$53.95
$3.97
52 Week High
$189.32
$19.00

Technical Indicators

Market Signals
Indicator
BELFA
FTRE
Relative Strength Index (RSI) 71.01 57.07
Support Level $155.74 $15.37
Resistance Level $187.73 $17.24
Average True Range (ATR) 7.44 1.20
MACD 1.54 -0.23
Stochastic Oscillator 85.26 61.21

Price Performance

Historical Comparison
BELFA
FTRE

About BELFA Bel Fuse Inc.

Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: